Paysign Q3 2026 net income more than triples to $6.74 million; Q3 2026 revenues rise 43% to $30.8 million

• Paysign's third-quarter 2026 net income more than tripled year-over-year to $6.74 million, while revenue rose 43% to $30.8 million.
• Pharma revenue more than doubled year-over-year to $16.62 million, while operating margin widened to 23.8%.
• A plasma customer plans to transfer payment processing for 113 centers by year-end; those centers generated trailing 12-month revenue of $11.3 million.
• Full-year 2026 revenue guidance remained $114 million–$117 million, while the net income outlook increased to $23 million–$24 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Paysign Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261109104686) on November 09, 2026, and is solely responsible for the information contained therein.